Loading...
XBRU
AZE
Market cap2.63bUSD
Dec 04, Last price  
9.28EUR
1D
3.80%
1Q
-26.06%
IPO
-66.13%
Name

Azelis Group NV

Chart & Performance

D1W1MN
XBRU:AZE chart
P/E
12.51
P/S
0.53
EPS
0.74
Div Yield, %
2.37%
Shrs. gr., 5y
0.84%
Rev. gr., 5y
15.13%
Revenues
4.24b
+2.07%
256,851,9992,095,008,0002,339,000,0002,827,296,0004,124,898,0004,152,225,0004,237,970,000
Net income
181m
+1.68%
-21,497,00047,973,00070,962,00067,756,000213,193,000177,704,000180,693,000
CFO
323m
-24.15%
61,676,00075,889,000117,018,00089,896,000368,594,000425,761,000322,939,000
Dividend
Jun 27, 20250 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Azelis Group NV engages in the distribution of specialty chemicals and food ingredients in Belgium and internationally. It serves various segments in life sciences, including personal care, pharma, food and health, specialty agri/horti, and homecare and industrial chemicals; and industrial chemicals industry, such as CASE, rubber and plastic additives, lubricants and metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper applications. Azelis Group NV was founded in 1996 and is headquartered in Antwerp, Belgium. Azelis Group NV operates as a subsidiary of Akita I S.À R.L.
IPO date
Sep 17, 2021
Employees
3,800
Domiciled in
BE
Incorporated in
BE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT